A detailed history of Umb Bank, N.A. transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Umb Bank, N.A. holds 75 shares of FLGT stock, worth $1,458. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75
Previous 61 22.95%
Holding current value
$1,458
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$19.6 - $25.06 $274 - $350
14 Added 22.95%
75 $1,000
Q2 2024

Jul 29, 2024

BUY
$19.09 - $22.57 $935 - $1,105
49 Added 408.33%
61 $1,000
Q1 2024

Apr 26, 2024

BUY
$21.55 - $29.29 $258 - $351
12 New
12 $0

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $588M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Umb Bank, N.A. Portfolio

Follow Umb Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.